We are elated to announce the closing of our oversubscribed Series Seed financing; we raised ~$2M in 2020, $1M of which was in the form of grant funding from the National Science Foundation (NSF).
These funds will be instrumental in advancing #VisiPlate to clinical trials, growing our team, and taking us one step closer to helping tens of millions of patients preserve their vision.